$ADXS If anyone missed the guy posting before :) "Merck’s Keytruda (pembrolizumab) anti-PD-1 therapy has secured approval in China for first-line treatment of metastatic squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy." pharmaceutical-technology.c...